Aligos Therapeutics
Biotechnology ResearchCalifornia, United States51-200 Employees
Aligos is a biopharmaceutical company developing targeted therapeutics to address unmet medical needs in liver and viral diseases including MASH, CHB and COVID-19.
Insights
Targeted Therapeutics Development Aligos Therapeutics focuses on developing targeted therapeutics for liver and viral diseases, offering solutions for unmet medical needs in conditions like MASH, CHB, and COVID-19. Identify healthcare institutions and providers specializing in these areas as potential sales targets.
Expansion of Product Portfolio With ongoing development of ALG-000184 for hepatitis B treatment and ALG-055009 for NASH, Aligos Therapeutics is expanding its product portfolio. Target pharmaceutical distributors and healthcare facilities in need of innovative treatments for liver diseases for potential collaborations or sales opportunities.
Key Executive Appointments Recent appointments of key personnel such as Vice Presidents of Business Development, Finance, and Investor Relations indicate strategic growth. Engage with these executives to explore partnership opportunities or present the value of Aligos Therapeutics' products to potential investors or stakeholders.
Financial Stability and Funding With revenue in the range of $10M - $50M and funding of $92M, Aligos Therapeutics demonstrates financial stability and the capacity for further growth. Approach investors or financial institutions interested in supporting companies within the biotechnology research sector.
Competitive Positioning and Market Presence Among similar biotechnology companies, Aligos Therapeutics stands out with a focus on liver and viral diseases. Conduct market analysis to identify areas where Aligos Therapeutics can differentiate itself and tailor sales pitches to showcase its unique positioning.
Similar companies to Aligos Therapeutics
Arrowhead Pharmaceuticals
556
$100M$1BQIAGEN
5.4K$1BEiger BioPharmaceuticals
26$10M$50MRegulus Therapeutics
46$10MMerck
41K$1BModerna
6.9K$1BAstraZeneca
73K$1BArcturus Therapeutics
204$10M$50M
Aligos Therapeutics Tech Stack
Aligos Therapeutics uses 8 technology products and services including W3 Total Cache, WP Rocket, Font Awesome, and more. Explore Aligos Therapeutics's tech stack below.
- W3 Total CacheCaching
- WP RocketCaching
- Font AwesomeFont Scripts
- RevsliderMiscellaneous
- X-Content-Type-OptionsMiscellaneous
- PHPProgramming Languages
- Yoast SEOSearch Engines
- Acquia Cloud Site FactoryWeb Hosting
Media & News
Aligos Therapeutics's Email Address Formats
Aligos Therapeutics uses at least 1 format(s):
| Aligos Therapeutics Email Formats | Percentage |
| FLast@aligos.com | 45% |
| Last@aligos.com | 9% |
| FMiddleLast@aligos.com | 1% |
| FLast@aligos.com | 45% |
Frequently Asked Questions
Where is Aligos Therapeutics's headquarters located?
Aligos Therapeutics's main headquarters is located at 1 Corporate Dr South San Francisco, California 94080 US. The company has employees across 4 continents, including North AmericaEuropeAfrica. What is Aligos Therapeutics's stock symbol?
Aligos Therapeutics is a publicly traded company; the company's stock symbol is ALGS. What is Aligos Therapeutics's official website and social media links?
Aligos Therapeutics's official website is aligos.com and has social profiles on LinkedIn.How much revenue does Aligos Therapeutics generate?
As of October 2024, Aligos Therapeutics's annual revenue reached $15M. What is Aligos Therapeutics's SIC code NAICS code?
Aligos Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Aligos Therapeutics have currently?
As of October 2024, Aligos Therapeutics has approximately 82 employees across 4 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer: L. M. B.Chief Scientific Officer: J. S.Chief Development Officer: S. C.. Explore Aligos Therapeutics's employee directory with LeadIQ.What industry does Aligos Therapeutics belong to?
Aligos Therapeutics operates in the Biotechnology Research industry. What technology does Aligos Therapeutics use?
Aligos Therapeutics's tech stack includes W3 Total CacheWP RocketFont AwesomeRevsliderX-Content-Type-OptionsPHPYoast SEOAcquia Cloud Site Factory. What is Aligos Therapeutics's email format?
Aligos Therapeutics's email format typically follows the pattern of . Find more Aligos Therapeutics email formats with LeadIQ. How much funding has Aligos Therapeutics raised to date?
As of October 2024, Aligos Therapeutics has raised $92M in funding. The last funding round occurred on Oct 23, 2023 for $92M.When was Aligos Therapeutics founded?
Aligos Therapeutics was founded in 2018.
Company Overview
- Headquarters
- 1 Corporate Dr South San Francisco, California 94080 US
- Website
- aligos.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- ALGS
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2018
- Employees
- 51-200
Media & News
Funding & Financials
- $92M
Aligos Therapeutics has raised a total of $92M of funding over 4 rounds. Their latest funding round was raised on Oct 23, 2023 in the amount of $92M.
- $10M$50M
Aligos Therapeutics's revenue is in the range of $10M$50M
Funding & Financials
- $92M
Aligos Therapeutics has raised a total of $92M of funding over 4 rounds. Their latest funding round was raised on Oct 23, 2023 in the amount of $92M.
- $10M$50M
Aligos Therapeutics's revenue is in the range of $10M$50M
Company Leadership
L. M. B.Chief Executive Officer- J. S.Chief Scientific Officer
S. C.Chief Development Officer
T. L.Vice President Of Clinical Early Development- D. C.Head Bioanalytical Sciences And Outsourcing
Employee Directory
- D. S.Executive Vice President
- T. L.Vice President Of Clinical Early Development
- D. C.Head Bioanalytical Sciences And Outsourcing
- C. W.Executive Director, Head Of Clinical Operations
- C. E.Senior Director And Head Of Quality
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
